123 related articles for article (PubMed ID: 8012958)
1. Genetic changes in epithelial solid neoplasia.
Rodriguez E; Sreekantaiah C; Chaganti RS
Cancer Res; 1994 Jul; 54(13):3398-406. PubMed ID: 8012958
[TBL] [Abstract][Full Text] [Related]
2. [Genetics of renal tumors].
Oláh E; Jakab Z; Balogh E
Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
4. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
[TBL] [Abstract][Full Text] [Related]
5. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
6. Primary vs. secondary neoplasia-associated chromosomal abnormalities--balanced rearrangements vs. genomic imbalances?
Johansson B; Mertens F; Mitelman F
Genes Chromosomes Cancer; 1996 Jul; 16(3):155-63. PubMed ID: 8814447
[TBL] [Abstract][Full Text] [Related]
7. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
8. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
9. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
[TBL] [Abstract][Full Text] [Related]
14. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
15. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
[TBL] [Abstract][Full Text] [Related]
16. Molecular implications of recurrent cytogenetic alterations in human small cell lung cancer.
Testa JR; Graziano SL
Cancer Detect Prev; 1993; 17(2):267-77. PubMed ID: 8402711
[TBL] [Abstract][Full Text] [Related]
17. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
18. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
20. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]